Category Archives: People

Hermès International: 2026 Half-year Results

Half-year information report as at the end of June 2026 Solid sales momentum and excellent results in the first halfRevenue amounted to €8.2 billion(+6% in the first quarter and +7% in the second quarter, at constant exchange rates)Recurring operating profitability reached 41.0% of salesAdjusted free cash flow grew by 18% Paris, 29 July 2026 The […]

BUREAU VERITAS – Delivering on our commitments with higher sequential organic growth in Q2 and continuous margin improvements

PRESS RELEASE Courbevoie, France – July 29, 2026 Delivering on our commitments with higher sequential organic growth in Q2 and continuous margin improvements    H1 2026 key figures1 Revenue of EUR 3,258.4 million in H1 2026, up 2.1% year-on-year and up 5.0% organically (with a sequential improvement in Q2 2026 at 5.5% organic growth), Adjusted […]

Global Success, Local Intelligent Manufacturing – JAECOO 5 Set to Begin Local Production in South Africa

WUHU, China, July 28, 2026 (GLOBE NEWSWIRE) — Recently, OMODA & JAECOO officially broke ground on its first South African plant, with key model JAECOO 5 joining the core production lineup. ICE, HEV, and BEV variants will be simultaneously introduced for local production. As South Africa’s fastest-growing automotive brand in 2025, with sales up 147% […]

Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston

NEEDHAM, Mass., July 29, 2026 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that the Company will present at Canaccord Genuity’s 46th Annual Growth Conference, taking place August 11-13, 2026, in Boston, […]

NewAmsterdam Pharma to Host Investor Day on August 5, 2026

NAARDEN, The Netherlands and MIAMI, July 29, 2026 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, […]

UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026

Conference Call and Webcast Scheduled for Wednesday, August 5th, 2026, at 10:00 AM ET PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report second quarter 2026 financial results on […]

Noom Health partners with Levrx to bring personalized weight management support into the pharmacy benefits experience

PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) — Noom Health, the enterprise arm of Noom and a leading behavior change platform, today announced a new integration with Levrx Technology, a pharmacy navigation and engagement platform that helps members understand medication coverage, costs and savings opportunities and take action. The partnership gives health plans, employers, consultants […]

Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights

Akebia to Host Conference Call on August 5 at 4:30 p.m. EDT CAMBRIDGE, Mass., July 29, 2026 (GLOBE NEWSWIRE) — Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the second quarter ended June 30, 2026 on Wednesday, August 5, 2026, following the close of the financial markets. Akebia will […]

Jushi Holdings Provides Update on Plan of Arrangement

BOCA RATON, Fla., July 29, 2026 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announces that, further to its News Releases of April 24, 2026 and June 24, 2026, it is proceeding to complete its previously announced plan of arrangement (the “Arrangement”) to […]

O-I Glass Reports Second Quarter 2026 Results

PERRYSBURG, Ohio, July 28, 2026 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI) today announced its financial results for the second quarter ended June 30, 2026.  Please follow the links below to view our second quarter 2026 earnings documents. O-I Glass Second Quarter 2026 Earnings Release and Financial TablesO-I Glass Second Quarter 2026 Earnings Presentation […]